Not cancer · Austria
Cystic fibrosis
How is it diagnosed today? All babies are checked for cystic fibrosis with the newborn blood spot test. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.1 open trial in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Medicines, physiotherapy and diet support. NHS
10 medicines are approved for this disease in Austria:
Show all 10
- Aztreonam (Cayston) – approved in 2009
- Colistimethate sodium (Colobreathe) – approved in 2012
- Deutivacaftor and tezacaftor and vanzacaftor (Alyftrek) – approved in 2025
- Ivacaftor (Kalydeco) – approved in 2012
- Ivacaftor and tezacaftor and elexacaftor (Kaftrio, Trikafta) – approved in 2020
- Levofloxacin (Quinsair) – approved in 2015
- Lumacaftor and ivacaftor (Orkambi) – approved in 2015
- Mannitol (Bronchitol) – approved in 2012
- Tezacaftor and ivacaftor (Symkevi, Symdeko) – approved in 2018
- Tobramycin (Vantobra, Tobi Podhaler, TOBI Podhaler) – approved in 2011
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (12)
- Acetylcysteine – approved for it in the US
- Alpha-tocopherol (Vitamine E Provepharm) – approved for it in France
- Ceftazidime (Fortum, Ceftazidime Arrow) – approved for it in France
- Ciprofloxacin (Ciflox, Ciprofloxacine Zentiva) – approved for it in France
- Colistimethate (Tadim) – approved for it in France
- Dornase alfa (Pulmozyme) – approved for it in the US, Switzerland, and France
- Meropenem (Meronem, Meropenem Panpharma) – approved for it in France
- Pancreatin (Eurobiol, Creon) – approved for it in France
- Phytomenadione (Vitamine K1 Cheplapharm, Phytonadione) – approved for it in the US and France
- Pancreas powder (Eurobiol) – approved for it in France
- Ursodeoxycholic acid (Cholurso, Delursan, Ursolvan) – approved for it in France
- Retinol palmitate (Vitamine A Provepharm) – approved for it in France
Being tested in people
1 open trial in Austria, 149 worldwide. See the trials
- ELX/TEZ/IVA (Phase 3)
- HSK31858, tablet (Phase 3)
- iLet Bionic Pancreas System (BP) (Phase 3)
- Intermittent Moxifloxacin + Standard Care (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 0 were in animals and 2 in the lab. See them
No proof it works
We checked 9 things people say help with this disease against the research. See how far each has been tested
No trial in people on record yet:
- Cannabis and cannabinoids (CBD, THC) (only single reports in people)
- High-dose vitamin C (only single reports in people)
- Ivermectin (animal studies only)
- Statins (animal studies only)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
1 open trial in Austria
Measuring antibiotic levels in the lungs of people with COPD or cystic fibrosis
2024-518337-29-00 · EU Clinical Trials Register
- Vienna – Medical University of Vienna
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
Available abroad (186 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Tests inhaled SPL84 in adults with cystic fibrosis and a specific gene mutation
NCT06429176 · ClinicalTrials.gov
Countries: Czechia, Germany, Spain and 6 more
- Prague, Czechia – Motol University Hospital
- Berlin, Germany – Charité Universitätsmedizin Berlin
- Potsdam, Germany – Klinikum Westbrandenburg CF Zentrum Potsdam
Age 18 and over
Contact the trial teamTests galvokimig against placebo in adults with non-cystic fibrosis bronchiectasis
NCT07720375 · ClinicalTrials.gov
Countries: Belgium, Bulgaria, Germany and 6 more
- Anderlecht, Belgium – Hopital Erasme
- Leuven, Belgium – UZ Leuven
- Sint-Niklaas, Belgium – Vitaz
Ages 18 to 80
Contact the trial teamTamoxifen safety in adults with cystic fibrosis who cannot take CFTR modulators
NCT07289035 · ClinicalTrials.gov
Countries: Italy
- Verona, Italy – Azienda Ospedaliera Universitaria Integrata Verona
Ages 18 to 64
Contact the trial teamTests a home airway clearance device in adults with non-cystic fibrosis bronchiectasis
NCT06487273 · ClinicalTrials.gov
Countries: Germany, France, United Kingdom and 3 more
- Aachen, Germany – Medizinische Klinik V University hospital
- Lübeck, Germany – Universitätsklinikum Schleswig-Holstein
- München, Germany – LMU Klinikum
Age 18 and over
Contact the trial teamComparing Ways to Collect Germ Samples in Children With Chronic Lung Disease
NCT07903792 · ClinicalTrials.gov
Countries: Spain
- Sabadell, Spain – Corporacio Sanitaria Parc Tauli
Ages 5 to 18
Contact the trial teamBlood vessel health in adults with cystic fibrosis compared with healthy adults
NCT07904325 · ClinicalTrials.gov
Countries: United Kingdom
- Liverpool, United Kingdom – Liverpool Heart and Chest Hospital NHS Foundation Trust
Age 40 and over
Contact the trial teamHow the body processes inhaled colistimethate in healthy adults and bronchiectasis patients
2025-524324-22-00 · EU Clinical Trials Register
Countries: Belgium, Poland
- Edegem, Belgium – SGS Belgium
- Bialystok, Poland – Centrum Medycyny Oddechowej Mroz sp. j.
- Jozefow, Poland – Biokinetica S.A.
Age 18 and over
Contact the trial teamViews of adults with cystic fibrosis on switching their current treatment
NCT07885410 · ClinicalTrials.gov
Countries: France
- Caen, France – CRCM Caen
- Giens, France – CRCM Giens
- Grenoble, France – CRCM Grenoble
Age 18 and over
Contact the trial teamTests inhaled ensifentrine for non-cystic fibrosis bronchiectasis
NCT06559150 · ClinicalTrials.gov
Countries: Spain, United Kingdom, Italy and 1 more
- A Coruña, Spain – Complexo Hospitalario Universitario A Coruña
- Barcelona, Spain – Hospital Clinic de Barcelona
- Barcelona, Spain – Hospital del Mar
Ages 18 to 80
Contact the trial teamTesting nasal cells to see how cystic fibrosis treatments might work
NCT07889973 · ClinicalTrials.gov
Countries: Italy
- Catania, Italy – Azienda Ospedaliero Universitaria Policlinico "G. Rodolico - San Marco"
- Genova, Italy – IRCCS Istituto Giannina Gaslini
- Milan, Italy – Policlinico di Milano Ospedale Maggiore | Fondazione IRCCS Ca' Granda
Ages 0 to 65
Contact the trial teamBlood test during pregnancy to check the baby for inherited gene disorders
NCT06147414 · ClinicalTrials.gov
Countries: France
- Paris, France – Hôpital Cochin, Maternité Port-Royal, service de Gynécologie obstétrique
Age 18 and over
Contact the trial teamTests inhaled CSL787 in adults with non-cystic fibrosis bronchiectasis
NCT07048262 · ClinicalTrials.gov
Countries: Belgium, Germany, Denmark and 9 more
- Brussels, Belgium – CHU Saint-Pierre
- Edegem, Belgium – Universitair Ziekenhuis Antwerpen
- Kortrijk, Belgium – Algemeen Ziekenhuis Groeninge
Ages 18 to 85
Contact the trial teamComparing two nebuliser devices to collect sputum from people with cystic fibrosis
NCT07879651 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Royal Brompton Hospital
Age 16 and over
Contact the trial teamMeasuring blood levels of elexacaftor, tezacaftor and ivacaftor in people with cystic fibrosis
NCT07809867 · ClinicalTrials.gov
Countries: Italy
- Florence, Italy – Azienda Ospedaliera Universitaria Meyer IRCCS
- Genoa, Italy – IRCCS Istituto Giannina Gaslini
- Milan, Italy – Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Age 6 and over
Contact the trial teamNew Pancreatic Enzyme Capsule NHS7108 for Adults With Exocrine Pancreatic Insufficiency
NCT07559175 · ClinicalTrials.gov
Countries: Bulgaria, Spain, United Kingdom and 4 more
- Lovech, Bulgaria – Medical Center Medconsult Pleven - Lovech Branch
- Pleven, Bulgaria – Medical Center Medconsult-Pleven
- Plovdiv, Bulgaria – MC Hipokrat-N - Gastroenterology
Ages 18 to 85
Contact the trial teamChecking How Consistent Glucose Sensors Are in Children With Cystic Fibrosis
NCT07851831 · ClinicalTrials.gov
Countries: France
- Bron, France – Hôpital Femme Mère Enfant (HFME)
Ages 10 to 17
Contact the trial teamCollects data on virus-based phage therapy for hard-to-treat infections
NCT06368388 · ClinicalTrials.gov
Countries: Belgium
- Leuven, Belgium – University Hospitals Leuven
No age limit given in the registry
Contact the trial teamTests inhaled SPL84 for safety in people with cystic fibrosis
2024-511184-28-00 · EU Clinical Trials Register
Countries: Germany, Spain, France and 4 more
- Berlin, Germany – Charite Universitaetsmedizin Berlin KöR
- Munich, Germany – Pneumologisches Studienzentrum München-West
- Potsdam, Germany – Klinikum Westbrandenburg CF Zentrum Potsdam
Age 18 and over
Contact the trial teamRegistry tracks donor lungs preserved with LungGuard device before transplant
NCT04930289 · ClinicalTrials.gov
Countries: Belgium, United States
- Leuven, Belgium – University Hospitals Leuven
- Baltimore, United States – Johns Hopkins University
- Boston, United States – Massachusetts General Hospital
No age limit given in the registry
Contact the trial teamFrench Questionnaire Check for Physiotherapy in Cystic Fibrosis Patients
NCT06273566 · ClinicalTrials.gov
Countries: France
- Caen, France – PSLA GDD
Ages 18 to 100
Contact the trial teamComparing two antibiotic plans for early Pseudomonas lung infection in bronchiectasis
NCT06368804 · ClinicalTrials.gov
Countries: France
- Amiens, France – Centre Hospitalier Universitaire Amiens - Picardie
- Brest, France – Centre Hospitalier Régional et Universitaire de Brest
- Creteil, France – Assistance Publique Hopitaux De Paris
Age 18 and over
Contact the trial teamUsing MRI scans to see how linaclotide affects the gut in cystic fibrosis
NCT07780344 · ClinicalTrials.gov
Countries: United Kingdom
- Nottingham, United Kingdom – Sir Peter Mansfield Imaging Centre
Ages 18 to 50
Contact the trial teamLooking for Home Sources of Mycobacteria Infection in People with Cystic Fibrosis
NCT07369414 · ClinicalTrials.gov
Countries: Germany
- Borstel, Germany – National and WHO-Supranational Reference Center for Mycobacteria, Research Center Borstel, Leibniz Lung Center
- Essen, Germany – Klinik für Pneumologie, Universitätsklinikum Essen
No age limit given in the registry
Contact the trial teamChecking heart and blood vessel health in adults with cystic fibrosis
NCT07692594 · ClinicalTrials.gov
Countries: United Kingdom
- Liverpool, United Kingdom – Liverpool Heart and Chest Hospital
Age 18 and over
Contact the trial teamStopping long-term macrolide antibiotics in stable bronchiectasis not caused by cystic fibrosis
2025-521493-33-00 · EU Clinical Trials Register
Countries: France
- Brest, France – Centre Hospitalier Régional et Universitaire de Brest
- Caen, France – Centre Hospitalier Universitaire de Caen Normandie
- Creteil, France – Assistance Publique Hopitaux De Paris
Age 18 and over
Contact the trial teamStudies lung and gut bacteria in cystic fibrosis patients on elexacaftor/tezacaftor/ivacaftor
NCT05937815 · ClinicalTrials.gov
Countries: France
- Bordeaux, France – CHU de Bordeaux - CRCM pédiatrique
- Grenoble, France – CHU de Grenoble Alpes CRCM pédiatrique
- Lille, France – CHRU de Lille CRCM Pédiatrique
Ages 6 to 17
Contact the trial teamVX-828 and deutivacaftor, with or without tezacaftor, in adults with cystic fibrosis
2025-523400-72-00 · EU Clinical Trials Register
Countries: Belgium, Czechia, Germany and 7 more
- Anderlecht, Belgium – Hopital Erasme
- Leuven, Belgium – UZ Leuven
- Brno, Czechia – Fakultni nemocnice Brno
Age 18 and over
Contact the trial teamMeasuring Thigh and Grip Strength in Adults Across Southern Europe
NCT07628530 · ClinicalTrials.gov
Countries: Spain
- Alcalá de Henares, Spain – University of Alcalá
Ages 18 to 89
Contact the trial teamHow antibiotics behave in people with cystic fibrosis on ETI therapy
NCT07629986 · ClinicalTrials.gov
Countries: France
- Roscoff, France – Fondation ILDYS
Age 12 and over
Contact the trial teamTesting molecules to correct gene faults in cystic fibrosis airway cells
NCT03670472 · ClinicalTrials.gov
Countries: France
- Amiens, France – Camsp Chu Amiens
- Bron, France – Hopital Femme Mere Enfant - Hcl - Bron
- Lille, France – Hôpital Calmette, CHU
Age 8 and over
Contact the trial teamTests ARCT-032 in adults with cystic fibrosis who cannot take CFTR modulators
NCT06747858 · ClinicalTrials.gov
Countries: Greece, United States
- Thessaloniki, Greece – Ippokratio General Hospital of Thessaloniki
- Thessaloniki, Greece – Geniko Nosokomeio Thessalonikis George Papanikolaou
- Boston, United States – Boston Children's Hospital
Age 18 and over
Contact the trial teamComparing Xylitol and Saline Nasal Rinses for Sinus Disease in Cystic Fibrosis
NCT05531630 · ClinicalTrials.gov
Countries: Belgium
- Leuven, Belgium – KU Leuven
Age 18 and over
Contact the trial teamLong-term study of vanzacaftor/tezacaftor/deutivacaftor in children with cystic fibrosis
NCT05844449 · ClinicalTrials.gov
Countries: Belgium, Switzerland, Germany and 9 more
- Leuven, Belgium – UZ Leuven
- Bern, Switzerland – Inselspital Bern
- Zurich, Switzerland – Kinderspital Zurich - Abteilung Pneumologie
Ages 1 to 17
Contact the trial teamLung Imaging and Breathing Tests in People With Cystic Fibrosis
NCT07192679 · ClinicalTrials.gov
Countries: United Kingdom
- Sheffield, United Kingdom – University of Sheffield MRI Unit
Age 1 and over
Contact the trial teamChecks breathing limits during exercise in people with cystic fibrosis taking a modulator drug
NCT07314229 · ClinicalTrials.gov
Countries: France
- Lille, France – University Hospital,
Age 18 and over
Contact the trial teamTracking recovery from severe lung flare-ups in people with cystic fibrosis
NCT07484607 · ClinicalTrials.gov
Countries: United Kingdom
- Cardiff, United Kingdom – Cardiff and Vale University Health Board
- Exeter, United Kingdom – Royal Devon and Exeter Hospital (Wonford)
- Leeds, United Kingdom – Leeds Adult CF Centre
Age 16 and over
Contact the trial teamBreath Sample Study for Asthma and Cystic Fibrosis Lung Disease
NCT04157361 · ClinicalTrials.gov
Countries: Czechia
- Olomouc, Czechia – University Hospital Olomouc
No age limit given in the registry
Contact the trial teamStudies CFTR gene control in epididymal cells from men with infertility or cystic fibrosis
NCT06045702 · ClinicalTrials.gov
Countries: France
- Brest, France – Antoine VALERI
Age 18 and over
Contact the trial teamStudying why cystic fibrosis flare-ups happen in people with CF
NCT06940531 · ClinicalTrials.gov
Countries: United Kingdom
- Birmingham, United Kingdom – Birmingham Heartlands Hospital
- Blackpool, United Kingdom – Blackpool Teaching Hospitals
- Bristol, United Kingdom – Medical Research Unit, Bristol Royal Infirmary
Age 5 and over
Contact the trial teamStudying Diabetes and Quality of Life in Adults With Cystic Fibrosis
NCT07442682 · ClinicalTrials.gov
Countries: Belgium
- Brussels, Belgium – Hôpital Erasme - HUB 808 route de Lennik 1070 Brussels Belgium
Age 18 and over
Contact the trial team
Showing 40 of 186. Use the filters to narrow the list.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- Multisystem Critical Illness in Cystic Fibrosis and Pregnancy: Recurrent Enterococcal Urosepsis From Indwelling Bilateral Nephrostomy Tubes.Cureus · 2026-10-16
- In peopleDelayed Liver Test Elevations During Long-Term Elexacaftor/Tezacaftor/Ivacaftor Therapy in Adults With Cystic Fibrosis.Pediatr Pulmonol · 2026-11-01
- Plethysmography as a Complementary Tool for Monitoring Response to CFTR Modulator Therapy in Children with Cystic Fibrosis: A Real-World Study.J Clin Med · 2026-10-27
- Navigating the hurdles: Parents' experiences of Elexacaftor/Tezacaftor/Ivacaftor during the early phase of treatment in young children with CF.Chronic Illn · 2026-11-14
- ReviewCystic Fibrosis and Related Disorders in Children With Pancreatic Disease: If You Screen for It, You Will Find It!Gastro Hep Adv · 2026-10-07
Is it true?
Saw something on social media? Fact-check it now.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Oesterreichische Lungenunion
Patient organisation for lung and airway diseases with a lung cancer focus area: information, videos, events, doctor search, online self-help. LuCE member.
Phone: 01 / 330 42 86
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (4)
- Cystic Fibrosis Europe
Federation of national CF patient organisations: patient perspective in standards of care, member training and information, patient-driven research (PORG), EU advocacy.
- EURORDIS – Rare Diseases Europe
Alliance of over 1,000 rare disease patient organisations, with a list of rare disease helplines by country.
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.